Joyance 2

Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company founded in 2017 that specializes in developing and commercializing a wearable microfluidic sensing platform. This innovative technology analyzes small droplets of sweat directly from the skin to provide insights into health, hydration, and athletic performance. The platform is designed to measure various biomarkers, including proteomics and inflammatory markers, allowing for personalized management of health and nutrition. Epicore's approach leverages over two decades of research in microfluidics and soft materials conducted by leading experts at Northwestern University. By offering a non-invasive and cost-effective solution, Epicore aims to enhance athletic performance and improve overall health monitoring for users.

Mae is a women's health care center providing pregnancy and postpartum support, tailored to women's needs. Mae is establishing a world in which high-quality, proactive care is the norm. Mae improves the quality of care for Black women by providing a trusted, digital-first health platform.

Sunnyside is a developer of an alcohol tracking application aimed at helping individuals cultivate healthier drinking habits. The app creates personalized plans based on users' current drinking patterns and personal goals. It also sends daily reminders via text messages to assist users in setting and maintaining limits on their alcohol consumption. By encouraging users to reduce their weekly drink intake, the application promotes benefits such as better sleep, improved diet, financial savings, and an overall enhanced sense of well-being.

Alba Health specializes in digital gut health support for children, utilizing artificial intelligence and gut microbiome testing. The company offers a microbiome testing service that provides comprehensive insights into a child's gut health through an easy-to-use stool test kit. This kit is analyzed in a certified laboratory, and the detailed results are returned to parents, who can then collaborate with dieticians to develop personalized action plans to enhance their child's health. Additionally, Alba Health anonymizes the test results, potentially contributing to broader discoveries that could improve children's overall health and well-being.

Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company founded in 2017 that specializes in developing and commercializing a wearable microfluidic sensing platform. This innovative technology analyzes small droplets of sweat directly from the skin to provide insights into health, hydration, and athletic performance. The platform is designed to measure various biomarkers, including proteomics and inflammatory markers, allowing for personalized management of health and nutrition. Epicore's approach leverages over two decades of research in microfluidics and soft materials conducted by leading experts at Northwestern University. By offering a non-invasive and cost-effective solution, Epicore aims to enhance athletic performance and improve overall health monitoring for users.

AOA Dx is a biotechnology company with a team of entrepreneurs that brings innovative, impactful, and cost-effective medical technologies from research and development into the hands of providers and patients. The company is driven by a mission to bring to market the first accurate early-stage non-invasive ovarian cancer diagnostic test that will improve clinical practice and help reduce patient mortality.

Ombre is a provider of microbiome testing kits that focus on personalized health solutions. The company offers subscription-based services that include customized microbiome testing and probiotics tailored to individual needs. Through its testing kits, Ombre delivers actionable insights aimed at preventing chronic diseases such as obesity, cystic fibrosis, and Alzheimer's. By addressing the root causes of gut-related issues, Ombre empowers customers to improve their overall health and well-being with science-backed interventions.

IDUN Technologies AG is a Swiss neurotechnology startup founded in 2017, specializing in the design and manufacture of advanced biosensors for wearable devices. The company’s flagship product, DRYODES, features dry conductive electrodes that facilitate bio-potential monitoring, including electrocardiography (ECG), electroencephalography (EEG), and electromyography (EMG). IDUN Technologies aims to integrate neuroscience into everyday products, allowing connected devices to understand and respond to users' emotional needs through real-time neuro-markers. By developing innovative biosensor technology and a comprehensive neurofeedback value chain—from electrode manufacturing to product integration—IDUN enables industries to harness brain signal monitoring for enhanced user experiences. The company's Guardian Neuro-Intelligence Platform exemplifies this approach, utilizing in-ear EEGs to provide actionable insights that improve product design and interaction. Through this integration of emotion intelligence and connected devices, IDUN Technologies aspires to foster a more connected and empathetic world.

Zone7 is a technology company founded in 2017 and based in Palo Alto, California, specializing in artificial intelligence-driven sports injury prediction software. The platform leverages data from wearable devices, medical records, and fitness profiles to forecast potential injuries, allowing for proactive measures to enhance athlete safety and performance. Zone7 serves over 30 professional sports franchises, offering insights that enable coaching staff to monitor athlete performance and injury risk effectively. Additionally, the technology is utilized in hospitals to ensure the well-being of medical staff by providing actionable recommendations for optimizing workload and recovery. By analyzing various data sources, Zone7 aims to protect and enhance the health and performance of both athletes and the elite workforce.

Clay is an education company focused on providing behavioral health solutions for early childhood education. The company specializes in identifying behavioral and developmental issues rapidly, enabling preschools to better support children facing disruptive behaviors and developmental delays. Clay offers a comprehensive range of behavioral and mental health services tailored for school communities, aiming to enhance the lives and outcomes of children and families. By delivering early, integrated access to necessary care, Clay seeks to empower families to raise healthy, resilient children while minimizing teacher absenteeism and addressing logistical challenges that can disrupt learning and development.

Expectful is a digital health and wellness platform focused on supporting women throughout their reproductive journey, specifically before, during, and after pregnancy. The app offers a range of resources, including guided meditations, mindfulness exercises, and expert advice tailored to the needs of expectant and new mothers. By providing a non-pharmacologic and accessible solution, Expectful aims to alleviate prenatal and postpartum stress, ultimately enhancing maternal and infant health outcomes. Its research-backed approach ensures that users receive effective tools to navigate the mental and emotional challenges associated with pregnancy and early motherhood.

Zone7 is a technology company founded in 2017 and based in Palo Alto, California, specializing in artificial intelligence-driven sports injury prediction software. The platform leverages data from wearable devices, medical records, and fitness profiles to forecast potential injuries, allowing for proactive measures to enhance athlete safety and performance. Zone7 serves over 30 professional sports franchises, offering insights that enable coaching staff to monitor athlete performance and injury risk effectively. Additionally, the technology is utilized in hospitals to ensure the well-being of medical staff by providing actionable recommendations for optimizing workload and recovery. By analyzing various data sources, Zone7 aims to protect and enhance the health and performance of both athletes and the elite workforce.

Folia Health, Inc., founded in 2016 and based in Cambridge, Massachusetts, has developed a web application that allows family caregivers to record daily observations regarding a patient's health. This innovative platform facilitates the entry of health outcomes data, which can be shared with the care team during medical appointments, thereby improving patient care. By focusing on the experiences of caregivers and patients dealing with complex diseases, Folia Health provides a valuable tool for parents of children with chronic conditions. The application supports precision diagnostics and patient-centered drug development by capturing longitudinal data and offering proprietary analytic methods. This approach aims to enhance the understanding of disease burden and treatment impact, contributing to a more home-centered, data-driven healthcare ecosystem.

AVA is a developer of a lightweight health device that monitors and filters pollutants. Its health device uses air quality sensors to filter small particles, which can be charged using a USB port and regulated through an application with the increasing levels of air impurities that enable users to protect themselves from specific pollutant details that can negatively affect their health.

Elma is a health technology company founded in 2017 and based in Barcelona, Catalonia. The company focuses on improving healthcare quality and affordability by integrating an insurance business model with an e-healthcare application. This application facilitates communication between doctors and patients, providing access to medical insurance and personalized medical services. Through its platform, patients can seek treatment for medical inquiries via chat, phone call, or video conference, allowing them to receive timely care whenever needed.

Limbic is a London-based company that specializes in mental healthcare technology. Founded in 2017, it develops a software development kit (SDK) that leverages machine learning to analyze heart rate data collected from wearable devices like the Apple Watch, allowing for the assessment of users' emotional states. Limbic also offers psychological therapies for adults, focusing on improving mental health through innovative solutions. Its platform supports healthcare professionals by providing tools for stress detection and facilitating clinical assessments, thereby enhancing the efficacy of psychological therapy. By combining AI technology with wearable devices, Limbic aims to address the growing challenges in mental health care and improve patient outcomes.

Wynd Technologies, Inc. is a manufacturer of air purifiers and a provider of environmental monitoring solutions aimed at enhancing indoor air quality. The company offers a range of products, including the portable Wynd air purifier, which features a removable sensor to monitor air quality and initiate purification. Wynd also provides advanced real-time air quality measurement and monitoring systems, with applications in both commercial and residential settings. Their solutions, such as Wynd Sentry and Wynd Nova, focus on detecting environmental disturbances and optimizing air quality, respectively, thereby improving health and safety in various environments, including hospitality and educational institutions. With a commitment to cloud-based technology, Wynd aims to integrate its air quality management systems into everyday appliances and HVAC systems, ensuring healthier spaces for users. Founded in 2014 and based in San Jose, California, Wynd Technologies was previously known as Claireau, Inc. before rebranding in 2015.

Pnoe is a company that specializes in metabolic analysis through its advanced device that accurately measures various physiological parameters, including metabolic, heart, lung, and cellular fitness. By analyzing breath data, Pnoe enables health professionals to prescribe tailored nutrition and training programs based on individual client needs. This approach helps fitness professionals identify limiting factors in their clients' health and performance, facilitating personalized interventions. Recognized for its rapid growth, Pnoe was ranked as one of the fastest growing companies in the Americas for 2023 by the Financial Times.

ProbiusDx Inc. is a manufacturer of portable diagnostic devices that utilize an electronic sensing platform to analyze multiple target proteins in real time. This technology allows healthcare professionals to detect and monitor blood concentrations, facilitating timely and appropriate therapy for patients requiring critical care in clinical settings. Founded in 2015 and based in El Cerrito, California, ProbiusDx aims to enhance diagnostic capabilities and improve patient outcomes through its innovative solutions.

Wynd Technologies, Inc. is a manufacturer of air purifiers and a provider of environmental monitoring solutions aimed at enhancing indoor air quality. The company offers a range of products, including the portable Wynd air purifier, which features a removable sensor to monitor air quality and initiate purification. Wynd also provides advanced real-time air quality measurement and monitoring systems, with applications in both commercial and residential settings. Their solutions, such as Wynd Sentry and Wynd Nova, focus on detecting environmental disturbances and optimizing air quality, respectively, thereby improving health and safety in various environments, including hospitality and educational institutions. With a commitment to cloud-based technology, Wynd aims to integrate its air quality management systems into everyday appliances and HVAC systems, ensuring healthier spaces for users. Founded in 2014 and based in San Jose, California, Wynd Technologies was previously known as Claireau, Inc. before rebranding in 2015.

Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company founded in 2017 that specializes in developing and commercializing a wearable microfluidic sensing platform. This innovative technology analyzes small droplets of sweat directly from the skin to provide insights into health, hydration, and athletic performance. The platform is designed to measure various biomarkers, including proteomics and inflammatory markers, allowing for personalized management of health and nutrition. Epicore's approach leverages over two decades of research in microfluidics and soft materials conducted by leading experts at Northwestern University. By offering a non-invasive and cost-effective solution, Epicore aims to enhance athletic performance and improve overall health monitoring for users.

Lark is a developer of a virtual chronic disease prevention and management platform that offers personalized support and counseling to users. Utilizing advanced artificial intelligence alongside human coaches and connected devices, Lark provides real-time, 24/7 assistance, helping individuals make healthier choices and manage chronic conditions effectively. The company has established CDC-recognized programs, including its Diabetes Prevention Program, Wellness Program, Diabetes Care Program, and Hypertension Program, which collectively serve 1.5 million users. These initiatives have shown clinically validated improvements in health outcomes, as documented in 11 peer-reviewed journals and analyst reports. Founded in 2011 by Julia Hu and Jeff Zira, Lark is headquartered in Mountain View, California.

Flux Bioscience is a company that originated from Stanford University, focusing on innovative point-of-care in vitro medical diagnostics. It has developed a portable biosensor platform designed to deliver medical-grade diagnostics directly to patients' homes. Utilizing a technology initially designed for reading and writing computer hard drives, Flux's platform analyzes blood, urine, or saliva samples to measure various biomarkers related to exercise, stress, fertility, and diet. These measurements are correlated with sleep and activity data obtained from wearable technologies. The biosensors are equipped with biochips that can detect multiple biomarkers simultaneously, providing accurate and sensitive real-time results through antibody-antigen interactions with magnetic nanoparticles. This approach empowers individuals to take charge of their healthcare and make informed lifestyle decisions.

Ombre is a provider of microbiome testing kits that focus on personalized health solutions. The company offers subscription-based services that include customized microbiome testing and probiotics tailored to individual needs. Through its testing kits, Ombre delivers actionable insights aimed at preventing chronic diseases such as obesity, cystic fibrosis, and Alzheimer's. By addressing the root causes of gut-related issues, Ombre empowers customers to improve their overall health and well-being with science-backed interventions.

ClosedLoop is a data science platform designed specifically for the healthcare sector, enabling organizations to leverage artificial intelligence to enhance patient outcomes and reduce costs. The platform features an extensive library of healthcare-specific model templates and offers an intuitive machine learning interface. This allows healthcare providers to develop customized predictive and prescriptive models tailored to their unique populations. ClosedLoop's Explainable AI technology supports clinical excellence and operational efficiency while facilitating value-based contracts and revenue enhancement. Recognized for its contributions to healthcare AI, ClosedLoop has won the CMS AI Health Outcomes Challenge and received accolades as Best in KLAS for Healthcare AI: Data Science Solutions in both 2022 and 2023. The company is headquartered in Austin, Texas.